<DOC>
	<DOCNO>NCT01489839</DOCNO>
	<brief_summary>The primary purpose study look biological biomarkers determine people gum disease worsen disease . A second objective study look effect periodontal treatment level biomarkers identify .</brief_summary>
	<brief_title>Biomarkers Periodontal Disease Progression</brief_title>
	<detailed_description>This multicenter clinical study investigate biomarkers periodontal disease progression . The study enroll 375 subject periodontal disease 125 periodontally healthy subject . All subject monitor clinically sample take every 2 month 12 month analysis inflammatory immunological biomarkers microbial specie . Subjects display periodontal disease progression great establish threshold receive periodontal rescue therapy progress periodontal site continue monitor . Periodontally healthy subject non-progressing site subject periodontal disease serve control . After 12 month , subject periodontal disease receive periodontal therapy consist 4 quadrant scale root planing . Periodontally healthy subject receive prophylaxis scale exit study . Following periodontal therapy , subject periodontal disease follow maintenance period 6 month clinical biological monitoring . Statistical analysis compare biomarkers microbial specie periodontally healthy subject subject periodontal disease , progress non-progressing periodontally diseased site , periodontally diseased site periodontal therapy .</detailed_description>
	<mesh_term>Disease Progression</mesh_term>
	<mesh_term>Periodontal Diseases</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<criteria>General Inclusion Criteria To eligible participate study , subject must meet following criterion : 1 . Ability understand , willingness ability read sign , informed consent form . 2 . Age least 25 year . 3 . Ability understand follow direction study procedure . 4 . Minimum 20 natural teeth , exclude third molar teeth ; least 12 teeth must premolars , first molar , second molar . 5 . Willingness professional dental prophylaxis scale duration disease progression monitoring phase ( 12 month ) . 6 . Willingness comply study procedure available duration study . 7 . For woman reproductive potential , willingness use highly effective contraception ( e.g. , license hormonal contraception , intrauterine device , abstinence , vasectomy partner ) . Specific inclusion criterion : Healthy periodontal subject must : 1 . Any tooth 3 mm less PD , irrespective attachment level , acceptable 2 . No teeth PD 4 mm concomitant attachment loss , exception distal second molar PD 4 mm concomitant CAL 2 mm acceptable . 3 . No radiographic evidence alveolar bone loss ( define distance great 2.0 mm measure radiographically CEJ crest alveolar bone ) ; exception mandibular incisor 3.0 mm alveolar bone loss measure radiographically CEJ crest alveolar bone accept . Mild periodontal disease subject : periodontal loss must meet following criterion must meet minimum criterion severe periodontal loss : 1 . At least 4 teeth least 1 site PD 5 mm concomitant CAL great equal 2 mm , radiographic evidence mesial distal alveolar bone loss around least 2 affected teeth . Alveolar bone loss define distance &gt; 2.0 mm measure radiographically CEJ crest alveolar bone . Subjects severe periodontal loss must meet following criterion : 1 . At least 8 separate teeth least 1 site PD 5 mm concomitant CAL great equal 3 mm , radiographic evidence mesial distal alveolar bone loss around least 2 affected teeth . Alveolar bone loss define distance &gt; 2.0 mm measure radiographically CEJ crest alveolar bone . 1 . Presence orthodontic appliance . 2 . The following condition note oral examination : Oral lichen planus Candidiasis Clinical leukoplakia Clinical erythroplakia Pemphigus Pemphigoid Other recurrent intraoral perioral vesiculobullous disease Aphthous ulceration ( major minor ) . Subjects present aphthous ulcer rescreened 2 week . They eligible ulcer heal subject history frequent recurrence . Herpetic lesion . Subjects present herpes labialis intraoral herpes rescreened 2 week . They eligible lesion heal subject history frequent recurrence . j. Traumatic ulcer . If subject present traumatic ulcer , he/she rescreened 23 week . The subject eligible ulcer heal . 3 . Acute necrotizing ulcerative gingivitis gross tooth decay , determine investigator . 4 . Root fragment , pericoronitis , endoperio lesion , dental abscess . Subjects may rescreened resolution dental condition . 5 . Pregnancy lactation . 6 . Requirement prophylactic antibiotic dental procedure ( e.g. , certain heart orthopaedic conditions* ) . 7 . Periodontal systemic antibiotic therapy previous 6 month . Routine dental prophylaxis allow . 8 . Use cigarette tobacco product within 1 year screen visit . 9 . Any medical condition might influence course periodontal disease treatment ( e.g. , diabetes [ irrespective level control ] , human immunodeficiency virus infection acquire immunodeficiency syndrome , use medication associate gingival hyperplasia ) . 10 . Chronic use nonsteroidal antiinflammatory drug ( e.g. , arthritis ) , define need , anticipate need , 3 week continuous use time enrollment course study . The use lowdose aspirin ( 81 mg/day ) prophylaxis allow . 11 . Current anticipate use chronic systemic corticosteroid , cyclosporine , systemic immunosuppressive agent . The use inhale corticosteroid allow . 12 . Hypersensitivity tetracycline ( e.g. , tetracycline , doxycycline , minocycline ) . 13 . Participation clinical study test drug , biologic , device , intervention within last 30 day . 14 . Any condition circumstance , opinion investigator , would place subject increase risk preclude his/her full compliance completion study .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>periodontal disease</keyword>
	<keyword>biomarkers</keyword>
	<keyword>periodontal treatment</keyword>
	<keyword>clinical attachment level</keyword>
</DOC>